Global Herpes Simplex Virus Treatment Market Size By Drug (Acyclovir, Valacyclovir, Famciclovir), By End User (Hospital pharmacies, Retail pharmacies), By Geographic Scope And Forecast

Herpes Simplex Virus Treatment Market Size And Forecast

Herpes Simplex Virus Treatment Market size was valued at USD 2371.74 Million in 2022 and is projected to reach USD 3909.42 Million by 2030, growing at a CAGR of 5.71% from 2023 to 2030.

The expansion of Herpes Simplex Virus Treatment is being fuelled by an increase in the incidence of HSV infection, the incidence of new infections, and continual microorganism changes that result in new strains. An increase in the means of transmission of the infectious disease, as well as a lack of sanitation in emerging countries, are driving the market for herpes simplex virus infection therapy. Women are infected with HSV-2 at a higher incidence than men, according to the World Health Organization. As the prevalence of HSV encephalitis rises, the market for this industry is likely to develop.

Global Herpes Simplex Virus Treatment Market Definition

So, sexually transmitted diseases, or STDs (you might also hear them called venereal diseases), are infections you get from sexual activity. They spread through body fluids like sperm, vaginal fluid, or blood. Things like bacteria, parasites, yeast, and viruses can cause them. You might notice symptoms like skin rashes, warts, intestinal issues, or even vaginal ulcers. To figure out if you have an STD, doctors use things like a physical exam or tests like ELISA, rapid plasma reagin tests, blood samples, or antibody absorption tests. For example, herpes (HSV) is caused by the herpes simplex virus. Herpes can pop up anywhere, but it's most common around your genitals and mouth. You can find more information on the CDC website.

So, there are basically two types of herpes simplex virus. HSV-1 is usually the culprit behind oral herpes, which gives you those annoying cold sores or fever blisters around your mouth and face. Now, HSV-2 is the one that mostly causes genital herpes – it’s responsible for the majority of outbreaks down there. The Centers for Disease Control and Prevention (CDC) says that over 16 percent of people in the US have HSV-2, and it's most common among African-American women. While HSV-1 can sometimes cause genital herpes (but not very often!), HSV-2 is the most common sexually transmitted infection that causes genital herpes (GH) and it's super contagious.

Living with HSV-2 can be a real challenge, as it can stick around for a long time and, in some cases, even be life-threatening. What's more, having HSV-2 makes you more susceptible to getting HIV. Now, when it comes to herpes, HSV-1 is less likely to come back compared to HSV-2. The Canadian Public Health Agency says that HSV-1 is actually more common than HSV-2 in most places. You'll also find that herpes is more widespread in areas with fewer resources. The tricky thing is, about 80% of herpes outbreaks are "silent," meaning you might not even know you have it! But when symptoms do show up, they can include those painful blistering sores, discomfort when you pee, a swollen lymphatic system, and a fever. And to top it all off, we still don't fully understand how long the virus can stay hidden or how it decides to flare up again.

Global Herpes Simplex Virus Treatment Market Overview

An increase in the incidence of HSV infection, an increase in the incidence of new infections, and continual microorganism changes that result in new strains are driving the global Herpes Simplex Virus Treatment Market. Furthermore, growth in the means of transmission of contagious diseases and a lack of sanitation in emerging countries are fueling the market growth for herpes simplex virus infection therapy. Women are infected with HSV-2 at a higher incidence than men, according to the World Health Organization.

As the prevalence of HSV encephalitis rises, the market for this industry is likely to develop. In addition to increasing research and development activity, the market is growing. The Herpes Simplex Virus Treatment Market has a lot of potential because of the massive burden of HSV infectious diseases on healthcare systems across the globe, which is driving huge investments in research and development of effective therapeutics for infectious diseases, is expected to boost the market’s growth. Furthermore, acyclovir is in high demand around the world.

So, what's making the Herpes Simplex Virus Treatment Market grow? Well, we're seeing more cases of herpes encephalitis, and there's a big need for better ways to treat those rare conditions. Plus, those sneaky microorganisms are always changing, giving us new virus strains to deal with. And, unfortunately, the ways herpes spreads are on the rise. But, let's not forget about the COVID-19 pandemic! It's really shaken things up. Researchers are finding links between the herpes simplex virus and SARS-CoV-2 in study after study, which has actually been good for the market. It's led to a bigger demand for antiviral drugs. Basically, COVID-19 and how it affects people with HSV are expected to keep pushing growth forward.

However, high treatment costs and an increase in the incidence of herpes simplex virus encephalitis may stymie market expansion and pose new challenges to the Herpes Simplex Virus Treatment Market. The negative problems associated with drug use and a lack of knowledge about herpes therapy are limiting the market’s expansion. On the other hand, attractive reimbursement policies and government backing for board authorities present new opportunities in the business.

Global Herpes Simplex Virus Treatment Market Segmentation Analysis

The Global Herpes Simplex Virus Treatment Market is segmented on the basis of Drug, End User, And Geography.

Herpes Simplex Virus Treatment Market, By Drug

• Acyclovir
• Valacyclovir
• Famciclovir

When it comes to medications, the market is split into three main playersAcyclovir, Valacyclovir, and Famciclovir. But acyclovir really stands out, dominating the Herpes Simplex Virus Treatment Market – in fact, it's worth mentioning again, acyclovir is the clear leader! It's an antiviral workhorse, often prescribed for herpes and used to tackle tricky issues like oral herpes and HSV encephalopathy. The way it works is pretty cleverit's a purine nucleoside analog that sneaks into the virus's DNA and morphs into acyclovir triphosphate, essentially stopping the virus from making copies of itself. Plus, because we're seeing more cases of HSV encephalitis, the demand for acyclovir is expected to climb. Sales for acyclovir hit an estimated $305.4 million in 2021, making up nearly 30% of the entire global Market. Being the go-to antiviral for HSV1 infections, acyclovir is creating a ton of exciting opportunities for manufacturers in the near future.

Herpes Simplex Virus Treatment Market, By End User

• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

Based on End User, The market is bifurcated into Hospital pharmacies, Retail pharmacies, and Online pharmacies. The retail pharmacy segment held the greatest market share, which is expected to increase over the forecast period. The most common cause of genital herpes is an increase in the number of people who suffer from lifestyle-related disorders such as stress, sedentary lifestyles, poor eating habits, and an unsanitary routine. This will help the global Herpes Simplex Virus Treatment Market flourish by continuously managing drugs.

This will make prescription-based pharmaceuticals even more mandatory, boosting the global pharmacy retail economy. As a result, these factors are expected to propel the worldwide Herpes Simplex Virus Treatment Market forward throughout the forecast period. The internet pharmacy is also contributing to the growth, thanks to the Covid-19 outbreak and lockdowns around the world. Furthermore, the online pharmacy’s doorstep service is a significant contributor to industry growth.

Herpes Simplex Virus Treatment Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

When we look at where Herpes Simplex Virus treatments are used around the globe, we divide the market into regions like North America, Europe, Asia Pacific, and the rest of the world. Right now, North America leads the pack in terms of how much money is spent on these treatments. Why? Well, according to the American Sexual Health Association, about half of all adults in the United States have HSV-1, the virus that causes oral herpes. Plus, about one in eight Americans has HSV-2. The National Institutes of Health even estimates that 90% of us will have been exposed to herpes by the time we're 50! So, with so many people affected, it's no wonder there's such a strong need for effective treatments, and that demand is really driving the Herpes Simplex Virus Treatment Market.

Key Players

The “Global Herpes Simplex Virus Treatment Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Agenus Inc, GlaxoSmithKline plc, Maruho Co Ltd, Merck & Co Inc, Sanofi Pasteur SA, Chimerix, Novartis AG, Apotex Inc, Admedus, Epi Health LLC. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• United BioPharma teamed up with the Shanghai Public Health Clinical Centre and Cheng Kung University’s Department of Microbiology and Immunology in October 2021 to test the efficacy of UB-621, a best-in-class long-acting treatment for genital herpes caused by simplex viruses 1 and 2. (HSV 1 and HSV2).
• In July 2021, AiCuris Anti-infective Cures AG began Phase III testing of pritelivir, a novel helicase-primase inhibitor, in immunocompromised individuals with acyclovir-resistant mucocutaneous herpes simplex virus (HSV) infections.
• Clear Probiotics will release its Synbiotic with Lactobacillus Rhamnosus GG in 2020. (LGG). This substance can aid in the prevention and treatment of herpes outbreaks.
• Perrigo plans to release its AB-rated generic Zovirax cream in 2020. This medicine contains acyclovir, which can be used to prevent additional herpes issues.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

We dig into the market with both qualitative (think "why") and quantitative (think "how much") analysis, breaking it down by different groups based on things like money and, well, everything else! We'll give you the market value (in good ol' USD Billion) for each of those groups. Plus, we'll tell you which region and segment we think will be the rocket ship – the one that's gonna grow the fastest and be the biggest. We'll also break down the US market region by region, showing you where the product/service is being used most and what's driving the market in each spot. Then there's the competitive scenewho's on top, what new stuff they're launching, who's partnering with who, and who's buying who. We're talking deep dives – company overviews, insights, product comparisons, and even SWOT analyses – for all the big players. Looking ahead, we'll give you the scoop on where the industry's going, factoring in new stuff happening, opportunities, and the hurdles in both new and mature markets. We'll even use Porter's five forces to really understand the market. To top it off, you get insight through the Value Chain, a look at market dynamics and growth opportunities in the years ahead and 6 months of analyst support after the sale.

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.